Validol

Quick links to important sections

Validol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Validol

Property Description
Active Ingredient Menthyl Isovalerate (Menthyl Valerate)
Form Sublingual Tablets, Oral Solution/Drops
Pharmacological Class Sedative, Reflex Vasodilatation Agent
Common Use Relief of Nervous Tension and Mild Restlessness
Origin Menthol Derivative, Defined Ester

Identity, Classification, and Composition

Validol is a widely recognized pharmaceutical preparation, formally classified as a sedative and a reflex vasodilatation agent. The medication's active substance is Menthyl Isovalerate (also known as Menthyl Valerate), which is a defined organic ester derived from isovaleric acid and menthol. Validol functions as a combination product because its unique physiological effect is realized through the synergistic presence of the menthyl isovalerate and free Menthol, which is necessary to trigger the reflexive action on nerve endings. This traditional compound is distinctively associated with pharmaceutical markets in Eastern Europe and the former Soviet Union states, where it has long been an accessible Over-the-Counter (OTC) preparation.

Form and General Purpose

The compound is predominantly supplied as small, white sublingual tablets intended for rapid dissolution under the tongue, though oral solution and drops are also available. This sublingual route of administration is a key differentiating feature, as it enables the quick, localized stimulation required for the drug's reflex-based action. The general purpose of Validol is to quickly achieve a calming effect on the nervous system and relieve states of mild nervous tension and generalized restlessness. Its mechanism involves acting as a sensory pathway modulator. This medicine helps ease discomfort by gently modulating the nervous system through this localized sensory pathway.

What side effects are possible with Validol?

Possible Side Effects and Safety Information

The official regulatory documentation for Menthyl Isovalerate (Validol) outlines potential adverse effects primarily linked to hypersensitivity and prolonged exposure. Safety data indicates that adverse reactions are typically mild and reported infrequently.


Documented Adverse Reactions

The side effects listed in official documents are categorized by the physiological systems affected, including:

  • Nervous System Disorders: Dizziness, headache, muscle tremor, and ataxia (loss of coordination).
  • Immune and Skin Disorders: Potential for generalized hypersensitivity reactions, a local allergic reaction in the oral cavity, and skin rash.
  • Cardiac Disorders: Bradycardia (slow heart rate).
  • Gastrointestinal System: Mild nausea.

Safety Classifications and Serious Reactions

Adverse effects such as nausea, dizziness, and lacrimation (excessive tear flow) are most often associated with prolonged use of the preparation and are noted to resolve spontaneously. The most serious safety consideration documented is the possibility of severe systemic hypersensitivity, including anaphylactic shock, which is listed as a potential, albeit extremely rare, adverse reaction.


Population and Condition-Specific Restrictions

Official labeling defines specific constraints and contraindications:

  • Pediatric Population: The medicine is contraindicated for use in individuals under 18 years old.
  • Vascular Conditions: The medicine is contraindicated in patients with severe arterial hypotension (very low blood pressure).
  • Use Limitation: A precautionary statement advises against using the medicine to treat severe heart pain, as this may mask a condition requiring urgent medical intervention.

These constraints define the high-level safety profile, emphasizing the risk of hypersensitivity and limitations based on age and existing conditions.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose from Validol as typically resulting from prolonged use of large doses or a single excessive exposure. The recognized clinical manifestations primarily involve the central nervous and gastrointestinal systems.

Documented Overdose Symptoms

The signs of overdose reported in official documentation focus on effects such as:

  • Central Nervous System (CNS) Depression: Manifested by drowsiness and dizziness.
  • Gastrointestinal Effects: Including nausea, vomiting, and abdominal discomfort.
  • Cardiovascular Changes: Potential for bradycardia (slow heart rate).

Required Emergency Actions

Upon recognizing symptoms of an overdose, the official guidance is explicit:

  1. Stop taking the drug immediately.
  2. The management of overdose is symptomatic and supportive, aimed at treating the specific signs and symptoms that appear.
  3. Immediate medical help must be sought if the signs of overdose are severe or if the patient's condition rapidly deteriorates.

In summary, the official overdose profile indicates that the primary risks are related to CNS and gastrointestinal upset. The crucial steps are to discontinue the drug and secure professional medical assessment for severe cases to ensure appropriate supportive care is provided.

Therapeutic Uses of Validol

The compound Menthyl isovalerate is associated with specific therapeutic uses within regions where it has been traditionally and commonly applied. As the active substance in the medication, it is commonly used to help with symptoms related to mild nervous tension, restlessness, and emotional irritability, which often arise from episodic stress.

It is relevant in contexts marked by increased discomfort or tension and may be part of symptomatic management for conditions such as functional cardialgia (non-cardiac chest discomfort), neuroses, and motion sickness. This use is applied when symptom clusters appear suddenly or fluctuate, such as during travel or episodes of increased distress. The medication contributes to easing the overall symptom load when symptoms interfere with daily comfort.

“The primary purpose is to help ease the overall symptom burden and support general well-being during symptomatic phases.”

Quick Fact: Relief for Mild Discomfort Validol is applied in scenarios where short-term symptomatic assistance is needed to manage symptoms that are episodic, non-severe, and associated with heightened physiological activity.

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Validol

Validol (Menthyl Isovalerate) eligibility is strictly defined by regulatory documents, distinguishing between populations permitted, restricted, or prohibited from use.

Eligibility Scope Status (Official Regulatory Term)
Standard Adult Population Permitted for use under standard labeled conditions
Pediatric Population (Under 18) Contraindicated or Not Recommended
Pregnancy and Lactation Not Recommended

Absolute Contraindications

Official labeling contraindicates the use of Validol in the following groups:

  • Patients with known hypersensitivity or individual intolerance to Menthyl Isovalerate, Menthol, or any excipients.
  • Patients presenting with acute myocardial infarction (AMI), primarily due to the risk of masking cardiac symptoms.
  • Individuals with severe arterial hypotension (very low blood pressure).

Restrictions and Conditional Use

Use requires caution in patients with certain pre-existing conditions. This includes individuals with coronary heart disease (CHD) and those with hepatic or renal impairment. Patients with diabetes mellitus must note that the sublingual tablet formulation commonly contains sugar excipients, which may restrict general eligibility.

What should I know about interactions with other medicines?

Validol Interactions with other medicines and products

This section summarizes the official interaction profile for Validol (Menthyl Isovalerate) as defined by regulatory documents from authoritative government health agencies.

Interaction Scope

The regulatory profile for Validol is largely defined by the absence of specific, explicit documentation in modern, consolidated government prescribing information, such as that provided by the FDA or EMA. Validol is a legacy preparation predominantly regulated in specific non-Western markets.

Interaction Entity Map (High-Level) Official Regulatory Status / Documented Finding
Contraindicated combinations None explicitly designated as contraindicated due to an interaction risk in the official regulatory documents reviewed.
Pharmacokinetic interactions No specific metabolic (e.g., CYP) or transporter-mediated interactions are documented.
Pharmacodynamic interactions No additive or synergistic effects with specific co-administered medicinal products are formally described.
Timing / Food / Alcohol No mandatory administration separation rules or warnings regarding food, alcohol, or herbal products are documented.

Connection to the Overall Interaction Profile

Based on available government regulatory records, no explicit constraints are formally imposed by the prescribing information regarding pharmacokinetic alteration, pharmacodynamic additive effects, or mandatory administration separation. The regulatory profile is structured by the non-documentation of specific interaction entities in the required authoritative sources.

Mechanism of Action

Validol operates via a dual mechanistic focus, influencing both the peripheral sensory system and the central nervous system to modulate physiological parameters.

TRPM8 Receptor Activation and Reflexive Modulation

Its menthol component functions as an agonist by activating the Transient Receptor Potential Melastatin 8 ( TRPM8) ion channels, which are expressed on sensory nerve endings in the oral mucosa. This sensory input triggers a reflex through the autonomic nervous system, resulting in modulation of central stress signaling and localized vasodilation (widening of blood vessels) in the upper body.

Direct Central Nervous System Sedation

Conversely, the menthyl isovalerate component is systemically absorbed and exerts a direct modulatory effect within the Central Nervous System (CNS). It interacts with neurotransmitter systems, influencing pathways associated with inhibitory GABAergic transmission. This action decreases overall neuronal excitability, influencing subsequent CNS activity associated with sedation and anxiolysis.

Smooth Muscle and Vascular Tone

The combined actions lead to a functional spasmolytic (anti-spasm) effect and moderate, transient vasodilation. This physiological consequence influences the parameters of smooth muscle tone and local circulation.

Dosage and Administration Information

How to Use Validol: Administration Guidelines

Administration of Validol (Menthyl Isovalerate) follows a specific set of guidelines, focusing on the route, dosing, and temporal limits for its use.


Administration Scope

Instruction Detail
Route of Administration The primary administration route for the tablet form is sublingual (under the tongue). Liquid preparations, where available, are administered via the oral route.
Dosing Schedule The standard single unit dose is one tablet. Administration is confined by a maximum limit of not more than five tablets over a 24-hour period.
Frequency Pattern Validol is used on an as-needed or episodic basis, typically administered 2–3 times a day in response to the temporary symptoms being addressed.
Age-Group Rules The medication is intended for adult use; prescribing information for children is generally not provided in the standard product documentation.

Procedural and Contextual Requirements

Guidelines describe precise administration steps for the drug’s correct action:

  1. Placement and Dissolution: The tablet is placed under the tongue and held there until it is completely dissolved. The tablet should not be chewed or swallowed whole.
  2. Timing: Administration is often directed to occur between meals.
  3. Dose Repetition: If the desired effect is not observed within approximately five minutes, a subsequent dose may be considered, provided the daily maximum is not exceeded.

The usage protocol defines the medication's role as short-term symptomatic assistance, with administration limited to temporary episodes of need and governed by the established dose ceiling.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Validol

Evidence for Mild Nervous Tension and Restlessness

Research has examined Validol's use in individuals experiencing mild nervous tension and general restlessness. The available data primarily comes from short-term clinical assessments and pharmacological studies that monitored the body’s immediate physiological response. These studies were generally applied in studies examining patient-reported experiences of discomfort and tension, focusing on the acute, temporary nature of these symptoms.

In these research scenarios, studies monitored subjective outcomes, such as how patients reported their perceived discomfort and tension levels. Research also explored objective measures, including changes in Heart Rate Variability (HRV), which is a key measure monitoring physiological strain or stress. Studies reported patterns of change in these physiological markers that were measured shortly after administration. The evidence describes short-term symptom patterns in populations with conditions characterized by fluctuating or episodic manifestations.

However, the certainty of this evidence remains low. Most reports stem from studies with modest sample sizes and methodologies developed outside current international trial standards. Consequently, the long-term effects are not fully established, and there is limited information on what the research shows regarding the sustained use of the compound.


Understanding Research Gaps and Uncertainty

The research landscape shows that evidence quality varies across studies, and certainty is generally assessed as low when measured against current international standards for evidence-based medicine. The main research limitations frames are the prevalence of older, less methodologically rigorous studies, modest sample sizes, and a strong focus on acute changes rather than long-term effects. The comparative evidence is lacking against current standard treatments for the studied conditions. The available findings provide context but not individual predictions and highlight what is known — and what is still uncertain about the compound's role.

Key Studies & References

  1. Menthyl isovalerate: A review of pharmacological properties and clinical use
  2. Review of the clinical evidence for Validol in functional cardialgia and neuroses (Representative Regional Source)

Frequently Asked Questions (FAQ)

Common questions about Validol (FAQ)


Q: Does Validol cause drowsiness or affect driving?

Official information indicates that the preparation may have a slight influence on the ability to drive vehicles or operate machinery. The active component is described in regulatory contexts as resulting in sedative and sleepy effects. Individuals may wish to consider this potential influence before undertaking activities that require alertness.


Q: How quickly can a person expect to feel the effect of Validol?

According to official product information, the effect of the drug has been reported to begin developing within approximately five minutes after administration. Research suggests the maximum relaxing effect may occur around 10 minutes following sublingual intake.


Q: What is the general duration of Validol's effect?

While the exact duration of the effect for a single dose is not specifically documented in regulatory summaries, the product is fundamentally defined as providing short-term symptomatic assistance. Its use is primarily intended for temporary episodes of discomfort or tension.


Q: Can Validol be used by pregnant or breastfeeding individuals?

Official prescribing information indicates that the use of Validol during pregnancy and lactation is generally not recommended because safety in these specific populations has not been established. In some regulatory contexts, use is only considered if the expected therapeutic benefit is determined to outweigh any potential negative impacts.


Q: Are there any official documents describing long-term effects of Validol?

Official documents note that adverse reactions have been observed in connection with the prolonged use of the preparation. Specifically, side effects such as nausea and dizziness have been reported to occur in these situations.


Q: Can Validol be crushed or chewed instead of letting it dissolve?

Official administration guidelines are very clear about the correct procedure for using Validol tablets. They explicitly state that the tablet must be held under the tongue until it is completely dissolved and must not be chewed or swallowed whole.


Q: Is the sensation of freshness or tingling a normal part of using Validol?

Yes, the sensation of freshness is a characteristic and normal part of the preparation's action. This occurs because the menthol component acts on cold receptors in the mouth, which triggers a localized sensory effect.


Q: Is Validol considered an herbal remedy or a pharmaceutical drug?

Validol is formally classified as a pharmaceutical product. Its active ingredient, Menthyl Isovalerate, is a chemically defined organic ester. It is categorized as a sedative and reflex vasodilatation agent.


Q: Does Validol have a strong odor or taste?

The active ingredient, Menthyl Isovalerate, is widely described in authoritative sources as having a characteristic menthol aroma. It is also noted to possess a sweet herbaceous odor.


Q: Does Validol affect blood pressure levels?

The preparation's mechanism involves reflex vasodilatation, which is the widening of blood vessels. Due to this potential effect on circulation, official prescribing information lists severe arterial hypotension, or very low blood pressure, as a contraindication for its use.


Q: How does the cooling sensation from Validol relate to its purpose?

The cooling sensation, triggered by the menthol component, is essential to the drug’s function. It initiates a reflex response through the nervous system that modulates central stress signaling, thereby influencing the body's response to tension and restlessness.


Q: Why is Validol sometimes associated with heart-related concerns?

The association stems from two key factors described in official regulatory texts. First, it is sometimes used for mild, functional heart discomfort. Second, regulatory warnings advise against using it for severe chest pain, as doing so could potentially mask a serious or urgent cardiac event.


Q: Is Validol regulated as a traditional medicine or a standard drug?

The compound is classified as a pharmaceutical preparation and is often referred to as a traditional compound. In the markets where it is predominantly used, it is commonly regulated as an accessible Over-the-Counter (OTC) product.


Q: Is there a link between Validol and changes in heart rhythm?

Official regulatory documentation lists Bradycardia (slow heart rate) as a potential adverse reaction. This indicates a reported link between the preparation and changes in heart rhythm.


Q: What kind of studies support the traditional use of Validol?

The evidence supporting the traditional use of Validol includes short-term clinical assessments and pharmacological studies. These studies typically focus on monitoring physiological responses and patient-reported experiences related to discomfort and tension.


Q: Are there any common misuses of Validol that I should be aware of?

A potential misuse would be deviating from the required administration route. Official administration guidelines explicitly mandate the sublingual route (dissolving under the tongue) and state the tablet should not be chewed or swallowed whole.


Q: Are there any foods or drinks that interact with Validol?

The official product information does not contain mandatory administration separation rules or warnings specifically regarding food or drinks. The regulatory profile is defined by the non-documentation of specific interaction entities.


Q: Is there a maximum number of days Validol is typically used?

Some prescribing information indicates a maximum duration of use of up to seven days. It is stated that if symptoms persist or worsen beyond this duration, medical consultation is required.

How should Validol be stored and disposed of?

Official Storage and Disposal Requirements

Validol (Menthyl Isovalerate) must be stored according to regulatory requirements to ensure its stability and potency up to the expiry date.

Storage Scope Requirement
Temperature Store at room temperature, typically not exceeding 25 C.
Protection Keep in a cool, dry, dark place and protect from heat and direct sunlight.
Container Store in the original packaging and ensure the container is tightly closed.
Safety Keep out of the reach of children at all times.
Disposal Do not flush unused or expired product down the sink or toilet.

For disposal, the best option is to use an authorized drug take-back program. If this is unavailable, mix the unused medicine with an undesirable substance (such as dirt or coffee grounds), place the mixture in a sealed container, and discard it in the household trash. Always scratch out personal information from the packaging before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Validol found in:

A-Z Index: